Clinical Trial Update: Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a neoantigen dendritic cell vaccine in combination with nivolumab for hepatocellular carcinoma and colorectal cancer with live…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Hepatocellular Carcinoma
• Liver Metastases

Drugs mentioned

• Neoantigen Dendritic Cell Vaccine
• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Hepatocellular Carcinoma, Hepatocellular Cancer | Phase 2 | Status: RECRUITING